Vimarsana
Biggest News Aggregation in the World

Mutational Burden News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mutational Burden. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mutational Burden Today - Breaking & Trending Today

The Evolution of Advanced Renal Cell Carcinoma - Vimarsana News

The Evolution of Advanced Renal Cell Carcinoma

Brian Rini, MD, and Hans Hammers, MD, PhD, discuss the evolution of management for advanced renal cell carcinoma (RCC), noting the role of biomarkers and its use in practice.

Bristol Myers Squibb's First Disclosures and New Data at ASH 2023 Highlight Company's Leadership and Progress in Cell Therapy, Targeted Protein Degradation and Novel Approaches in Hematology -November 02, 2023 at 11:35 am EDT - Vimarsana News

Bristol Myers Squibb's First Disclosures and New Data at ASH 2023 Highlight Company's Leadership and Progress in Cell Therapy, Targeted Protein Degradation and Novel Approaches in Hematology -November 02, 2023 at 11:35 am EDT

First presentation of results from primary analysis of Phase 2 TRANSCEND FL study evaluating second-line treatment with Breyanzi® in relapsed or refractory follicular lymphoma demonstrate its...

Understanding Lynch Syndrome and Associated Cancer Risk: Treatment Advances - Vimarsana News

Understanding Lynch Syndrome and Associated Cancer Risk: Treatment Advances

In this fifth episode of OncChats: Understanding Lynch Syndrome and Cancer Risk, Fay Kastrinos, MD, MPH, highlights progress made with regard to colon cancer treatment and Lynch syndrome, including leveraging immunotherapy.

Global Immuno-Oncology Diagnostics Markets, 2021-2025: Checkpoint Assays, Cytokine Assays, Genomic Germline, Genomic Tumour, Tumor Microenviroment - Vimarsana News

Global Immuno-Oncology Diagnostics Markets, 2021-2025: Checkpoint Assays, Cytokine Assays, Genomic Germline, Genomic Tumour, Tumor Microenviroment

4.3.2 Shifting Role of Diagnostics 4.3.3 Multiplexing and Foundation One 4.3.4 The Disruption Dynamic 4.3.6 The Next Five Years 5. Cancer Immuno-Oncology Diagnostics Recent Developments 5.1 Recent Developments - Importance and How to Use This Section 5.1.1 Importance of These Developments 5.1.2 How to Use This Section Qiagen Expands Immuno-Oncology Portfolio IncellDx Awarded PD-L1 Detection Patent FDA Approves CDx for Trastuzumab Promega Nabs CE Mark for Microsatellite Instability IVD ArcherDx partners with AstraZeneca for Immuno-Oncology Germline Results Guides Precision Therapy ...